Literature DB >> 8603766

Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by suppressing glycolysis in conscious rats.

J K Kim1, J K Wi, J H Youn.   

Abstract

The effects of elevated plasma free fatty acid (FFA) levels on insulin -stimulated whole-body and skeletal muscle glucose transport, glucose uptake, glycolysis, and glycogen synthesis were studied in conscious rats during hyperinsulinemic-euglycemic clamps with (n = 26) or without (n = 23) Intralipid and heparin infusion. Whole-body and skeletal muscle glucose uptake, glycolysis, and glycogen synthesis were estimated using D-[3-3H]glucose and 2-[14C]deoxyglucose (study 1), and glucose transport activity was assessed by analyzing plasma kinetics of L-[14C]glucose and 3-O-[3H]-methylglucose (study 2). Plasma FFA levels decreased during the clamps without intralipid but increased above basal during the clamps with Intralipid infusion (P < 0.01 for both). Elevated plasma FFA levels decreased insulin-stimulated whole-body glucose uptake by approximately 15% and approximately 20% during physiological and maximal insulin clamps, respectively (P < 0.01). Similarly, insulin-stimulated glucose uptake was also decreased in individual skeletal muscles with Intralipid infusion (P < 0.05). The most profound effect of elevated plasma FFA levels was a 30-50% suppression of insulin-stimulated glycolysis in whole body and individual skeletal muscles in both clamps. In contrast, physiological insulin-stimulated glycogen synthesis was increased with elevated plasma FFA levels in whole body and individual skeletal muscles (P < 0.05). Glucose-6-phosphate (G-6-P) levels were increased in soleus and extensor digitorum longus (EDL) muscles with Intralipid infusion in both clamps (P < 0.05). Intralipid infusion did not alter the time profiles of plasma L-glucose and 3-O-methylglucose after an intravenous injection during maximal insulin clamps, and compartmental analysis indicated no significant effect of elevated FFA levels on glucose transport activity in insulin-sensitive tissues (P > 0.05). Thus, elevated plasma FFA decreased insulin-stimulated glucose uptake in skeletal muscle by suppressing glycolysis and increasing G-6-P levels. These findings suggest that the classic glucose-fatty acid cycle was the predominant mechanism underlying the inhibitory effect of FFA on skeletal muscle glucose uptake.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8603766     DOI: 10.2337/diab.45.4.446

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  21 in total

1.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.

Authors:  O Gavrilova; B Marcus-Samuels; D Graham; J K Kim; G I Shulman; A L Castle; C Vinson; M Eckhaus; M L Reitman
Journal:  J Clin Invest       Date:  2000-02       Impact factor: 14.808

2.  Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo.

Authors:  L Getty; A E Panteleon; S D Mittelman; M K Dea; R N Bergman
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

3.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

4.  Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.

Authors:  J K Kim; A Zisman; J J Fillmore; O D Peroni; K Kotani; P Perret; H Zong; J Dong; C R Kahn; B B Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  Role of the glucosamine pathway in fat-induced insulin resistance.

Authors:  M Hawkins; N Barzilai; R Liu; M Hu; W Chen; L Rossetti
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

6.  Novel metabolic disorders in skeletal muscle of Lipodystrophic Bscl2/Seipin deficient mice.

Authors:  Wenqiong Xu; Hongyi Zhou; Hongzhuan Xuan; Pradip Saha; Gongxian Wang; Weiqin Chen
Journal:  Mol Cell Endocrinol       Date:  2018-12-04       Impact factor: 4.102

7.  Acute interleukin-6 administration does not impair muscle glucose uptake or whole-body glucose disposal in healthy humans.

Authors:  Adam Steensberg; Christian P Fischer; Massimo Sacchetti; Charlotte Keller; Takuya Osada; Peter Schjerling; Gerrit van Hall; Mark A Febbraio; Bente Klarlund Pedersen
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

8.  Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  B S Andresen; S Olpin; B J Poorthuis; H R Scholte; C Vianey-Saban; R Wanders; L Ijlst; A Morris; M Pourfarzam; K Bartlett; E R Baumgartner; J B deKlerk; L D Schroeder; T J Corydon; H Lund; V Winter; P Bross; L Bolund; N Gregersen
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

9.  Non-Esterified Fatty Acids and Risks of Frailty, Disability, and Mobility Limitation in Older Adults: The Cardiovascular Health Study.

Authors:  Peter Ahiawodzi; Luc Djousse; Joachim H Ix; Jorge R Kizer; Russell P Tracy; Alice Arnold; Anne Newman; Kenneth J Mukamal
Journal:  J Am Geriatr Soc       Date:  2020-09-22       Impact factor: 5.562

10.  Muscle contraction, but not insulin, increases microvascular blood volume in the presence of free fatty acid-induced insulin resistance.

Authors:  April C Inyard; Daniel G Chong; Alexander L Klibanov; Eugene J Barrett
Journal:  Diabetes       Date:  2009-08-12       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.